Netherlands· NL-419c6084238f

Buspiron HCl Mylan 10 mg, tabletten

A buspirone product containing buspiron hydrochloride, registered in Netherlands by Mylan Pharmaceuticals Limited. The same ATC class is registered in 12 of our 19 countries.

ATC N05BE01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about buspiron hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Buspirone is registered in 12 of 19 countries.

Countries holding a registration under ATC N05BE01 (buspirone), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search buspirone products by name

Buspirone · ATC N05BE01

12 / 19 countries

Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Netherlands
Norwayprice
Polandprice
Sweden
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of buspirone costs, country by country.

Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Buspirone · price per daily dose (30 mg)

USD · FX 28 Sept 2026

FR France$0.60

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: BUSPIRON HYDROCHLORIDE
Manufacturer: Mylan Pharmaceuticals Limited
Country: Netherlands (NL)
ATC code: N05BE01
ATC class: Buspirone
Defined daily dose: 30 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
27118

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

258 interactions on record for buspirone.

Graded by severity as the source publishes them — 22 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check buspirone against other medicines How interaction checks work

Buspirone · interactions on record

258 records

22 severe
118 moderate
118 info

Most severe, free to view

OndansetronA04AA01severe
GranisetronA04AA02severe
DolasetronA04AA04severe
PalonosetronA04AA05severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Buspirone in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All buspirone products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

Czechia · Buspiron-Egis
Germany · Busp
Denmark · Buripal, Buspiron Actavis
Finland · Anksilon, Buspiron Ratiopharm
France · Buspirone Sandoz, Buspirone Viatris
United Kingdom (Northern Ireland) · Buspirone Accord-Uk, Buspirone Hydrochloride
Greece · Antipsichos, Bergamol
Hungary · Spitomin
Lithuania · Spitomin
Latvia · Spitomin
Norway · Buripal, Buspirone Orion
Poland · Spamilan
Portugal · Ansiten, Busansil
Romania · Spitomin
Sweden · Anksilon, Buripal
Slovakia · Spitomin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ed4ae69f-efda-4358-afb8-3bdfa5849f0a
GET /v1/drugs/ed4ae69f-efda-4358-afb8-3bdfa5849f0a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h27118_smpc.pdf",
  "strength": null,
  "atc_label": "Buspirone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg27118",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "BUSPIRON HYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h27118.pdf",
  "authorised_at": "2002/01/10",
  "procedure_number": "NL/H/4536/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "27118",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about buspirone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console